Literature DB >> 9572676

Ammonia and manganese increase arginine uptake in cultured astrocytes.

A S Hazell1, M D Norenberg.   

Abstract

Recent work has suggested a possible role for nitric oxide (NO) in the development of hepatic encephalopathy (HE). In this study, we examined the effect of ammonia and manganese, factors implicated in the pathogenesis of HE, on the transport of arginine (a precursor of NO) into primary cultures of astrocytes. Treatment with 5 mM ammonia for 1-4 days produced a maximal (53%) increase in L-arginine uptake at 3 days when compared to untreated cells. Kinetic analysis following 4-day treatment with 5 mM ammonia revealed an 82% increase in the Vmax and a 61% increase in the Km value. Similar analysis with 100 microM manganese showed a 101% increase in Vmax and a 131% increase in the Km value. These results suggest that both manganese and ammonia alter L-arginine uptake by modifying the transporter for arginine. A decrease of 32% in the non-saturable component of L-arginine transport was also observed following treatment with ammonia. When cultures were treated separately with 5 mM ammonia and 100 microM manganese for 2 days, the uptake of L-arginine increased by 41% and 57%, respectively. Combined exposure led to no further increase in uptake. Our results suggest that ammonia and manganese may contribute to the pathogenesis of HE by influencing arginine transport and thus possibly NO synthesis in astrocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572676     DOI: 10.1023/a:1022411012512

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  39 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat and human brain in flask cultures.

Authors:  J Booher; M Sensenbrenner
Journal:  Neurobiology       Date:  1972

3.  Effects of ammonia on synaptosomal membranes.

Authors:  J E O'Connor; C Guerri; S Grisolía
Journal:  Biochem Biophys Res Commun       Date:  1984-03-15       Impact factor: 3.575

4.  Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images.

Authors:  E Inoue; S Hori; Y Narumi; M Fujita; K Kuriyama; T Kadota; C Kuroda
Journal:  Radiology       Date:  1991-05       Impact factor: 11.105

5.  Nitroarginine, an inhibitor of nitric oxide synthetase, attenuates ammonia toxicity and ammonia-induced alterations in brain metabolism.

Authors:  E Kosenko; Y Kaminsky; E Grau; M D Miñana; S Grisolía; V Felipo
Journal:  Neurochem Res       Date:  1995-04       Impact factor: 3.996

6.  Increased nitric oxide synthase activities and L-[3H]arginine uptake in brain following portacaval anastomosis.

Authors:  V L Rao; R M Audet; R F Butterworth
Journal:  J Neurochem       Date:  1995-08       Impact factor: 5.372

7.  Morphologic effects of ammonia on primary astrocyte cultures. I. Light microscopic studies.

Authors:  J B Gregorios; L W Mozes; L O Norenberg; M D Norenberg
Journal:  J Neuropathol Exp Neurol       Date:  1985-07       Impact factor: 3.685

8.  Metabolic abnormalities and grade of encephalopathy in acute hepatic failure.

Authors:  A M Mans; M R DeJoseph; R A Hawkins
Journal:  J Neurochem       Date:  1994-11       Impact factor: 5.372

9.  Arginine in thioacetamide-induced hepatogenic encephalopathy in rats: activation of enzymes of arginine metabolism to glutamate.

Authors:  J Albrecht; W Hilgier
Journal:  Acta Neurol Scand       Date:  1986-05       Impact factor: 3.209

10.  Activation of arginine metabolism to glutamate in rat brain synaptosomes in thioacetamide-induced hepatic encephalopathy: an adaptative response?

Authors:  J Albrecht; W Hilgier; U Rafałowska
Journal:  J Neurosci Res       Date:  1990-01       Impact factor: 4.164

View more
  13 in total

Review 1.  Oxidative stress in the pathogenesis of hepatic encephalopathy.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 2.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

Review 3.  Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia.

Authors:  K V Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

Review 4.  Cerebral blood flow in acute liver failure: a finding in search of a mechanism.

Authors:  Javier Vaquero; Chuhan Chung; Andres T Blei
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 5.  Ammonia neurotoxicity: role of the mitochondrial permeability transition.

Authors:  K V Rama Rao; A R Jayakumar; D M Norenberg
Journal:  Metab Brain Dis       Date:  2003-06       Impact factor: 3.584

Review 6.  Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury.

Authors:  Marcelo Farina; Daiana Silva Avila; João Batista Teixeira da Rocha; Michael Aschner
Journal:  Neurochem Int       Date:  2012-12-21       Impact factor: 3.921

7.  Nitric oxide production in striatum and pallidum of cirrhotic rats.

Authors:  Sergio Montes; Francisca Pérez-Severiano; Paula Vergara; José Segovia; Camilo Ríos; Pablo Muriel
Journal:  Neurochem Res       Date:  2006-01       Impact factor: 3.996

Review 8.  Mechanisms of ammonia-induced astrocyte swelling.

Authors:  M D Norenberg; K V Rama Rao; A R Jayakumar
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.655

Review 9.  Alterations of blood brain barrier function in hyperammonemia: an overview.

Authors:  Marta Skowrońska; Jan Albrecht
Journal:  Neurotox Res       Date:  2011-08-27       Impact factor: 3.911

Review 10.  Role of astrocytes in manganese mediated neurotoxicity.

Authors:  Marta Sidoryk-Wegrzynowicz; Michael Aschner
Journal:  BMC Pharmacol Toxicol       Date:  2013-04-18       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.